Compounds > catechin

catechin and Acinetobacter Infections

catechin has been researched along with Acinetobacter Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Guo, H; Hao, S; He, R; Li, L; Li, Y; Shi, F; Song, X; Tang, H; Yan, Q; Ye, G; Zhao, L; Zou, Y1
Kwon, DH; Lee, S; Razqan, GS1
Babcock, G; Gardner, J; Hyon, SH; Neely, A; Osterburg, A1
Betts, JW; Haswell, SJ; Kelly, SM1

Other Studies

4 other study(ies) available for catechin and Acinetobacter Infections

ArticleYear
Epigallocatechin-3-gallate reduces liver and immune system damage in Acinetobacter baumannii-loaded mice with restraint stress.
    International immunopharmacology, 2021, Volume: 92

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Antioxidants; Catechin; Disease Models, Animal; Female; Immune System; Inflammation; Liver Diseases; Male; Mice; Mice, Inbred ICR; Oxidative Stress

2021
Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Jan-15, Volume: 24

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catechin; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts

2017
Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Camellia; Catechin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Mafenide; Microbial Sensitivity Tests; Microbial Viability

2009
Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antioxidants; Biflavonoids; Catechin; Drug Synergism; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia

2011